Financial Gravity Asset Management, Inc. Immunity Bio, Inc. Transaction History

Financial Gravity Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 26, 2024	BUY	$3.23 - $6.17 $48 - $92	15 Added 750.0%	17 $94,000
Q1 2024 May 13, 2024	BUY	$3.23 - $6.17 $106 - $203	33 Added 1650.0%	35 $193,000
Q4 2023 Jun 26, 2024	SELL	$1.25 - $5.21 $41 - $171	-33 Reduced 94.29%	2 $11,000
Q3 2023 Nov 15, 2023	SELL	$1.29 - $3.1 $1 - $3	-1 Reduced 33.33%	2 $0
Q2 2023 Aug 08, 2023	BUY	$1.53 - $6.41 $4 - $19	3 New	3 $26,000
Q4 2022 Feb 15, 2023	BUY	$4.35 - $6.77 $21 - $33	5 New	5 $5,000

202

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.